Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

45.88
BATS BZX Real-Time Price
As of 12:22pm ET
 -0.68 / -1.46%
Today’s Change
19.59
Today|||52-Week Range
62.68
-25.92%
Year-to-Date
The 3 Best Biotech Stocks for 2017
Dec 08 / MotleyFool.com - Paid Partner Content
4 Factors That Catapulted Ionis Pharmaceuticals Inc. 68% Higher in November
Dec 04 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks
Dec 06 / MotleyFool.com - Paid Partner Content
3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline
Dec 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close46.56
Today’s open46.71
Day’s range45.82 - 47.30
Volume32,441
Average volume (3 months)2,193,029
Market cap$5.6B
Dividend yield--
Data as of 12:22pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-51.58%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book27.91

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+0.76+0.58%
MNKMallinckrodt Plc-0.16-0.31%
VRXValeant Pharmaceutic...+0.03+0.19%
OPKOPKO Health Inc+0.07+0.69%
Data as of 12:26pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts


Search for Jobs